Tichostatin A inhibiting migration and invasion of human gastric carcinoma SGC-7901 cells via up-regulating protocadherin 9

CHENG Qi LIU Xiao-dong XU Wan-ling*

doi:10.16098/j.issn.0529-1356.2019.05.009

PDF(404 KB)

Acta Anatomica Sinica ›› 2019, Vol. 50 ›› Issue (5) : 595-600. DOI: 10.16098/j.issn.0529-1356.2019.05.009

Tichostatin A inhibiting migration and invasion of human gastric carcinoma SGC-7901 cells via up-regulating protocadherin 9

CHENG Qi¹ LIU Xiao-dong² XU Wan-ling ^3*

Author information +

History +

Abstract

Objective To investigate the effect of trichostatin A (TSA) on migration and invasion in human gastric carcinoma SGC-7901 cells and its possible mechanism. Methods SGC-7901 cells were cultured in vitro and treated with TSA (5, 10, 20, 40, 80, 160 nmol/L) for 48 hours, and then the cell viability was detected by cell counting kit 8(CCK-8) assay. The protocadherin 9 (PCDH9) high-expression SGC-7901 cells were stably established by transfecting with eukaryotic expression vector (pCMV6-PCDH9). Transwell assay was used to determine the abilities of migration and invasion. The mRNA expression level of PCDH9 were measured by RT-PCR. Western blotting was performed to analyze the protein expression of PCDH9, Snail, E-cadherin, matrix metalloproteinase (MMP)-2 and MMP-9. Results TSA remarkably reduced the cell viability of SGC-7901 cells in excess of 80 nmol/L (P<0.05). However, in a dose-dependent manner, low-level TSA (5-20 nmol/L) suppressed migration and invasion of SGC-7901 cells (P<0.05), down-regulated the protein levels of Snail, MMP-2 and MMP-9 (P<0.05), and up-regulated the protein levels of PCDH9 and E-cadherin (P<0.05). Meanwhile, high expression of PCDH9 also inhibited migration and invasion of SGC-7901 cells (P<0.05), down-regulated the protein levels of Snail, MMP-2 and MMP-9 (P<0.05), and up-regulated the protein level of E-cadherin (P<0.05). Conclusion TSA may inhibit migration and invasion of SGC-7901 cells most likely via up-regulating PCDH9, and then down-regulating the protein levels of Snail, MMP-2 and MMP-9, and up-regulating the protein level of E-cadherin.

Key words

Trichostatin A / Protocadherin 9 / Gastric carcinoma / SGC-7901 cell / Western blotting / Human

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

CHENG Qi LIU Xiao-dong XU Wan-ling. Tichostatin A inhibiting migration and invasion of human gastric carcinoma SGC-7901 cells via up-regulating protocadherin 9[J]. Acta Anatomica Sinica. 2019, 50(5): 595-600 https://doi.org/10.16098/j.issn.0529-1356.2019.05.009

References

［1］ McLean MH, El-Omar EM. Genetics of gastric cancer ［J］. Nat Rev Gastroenterol Hepatol, 2014, 11(11):664-674.

［2］ Kalnina Z, Meistere Ⅰ, Kikuste Ⅰ, et al. Emerging blood-based biomarkers for detection of gastric cancer ［J］. World J Gastroenterol, 2015, 21(41):11636-11653.

［3］ Hichino A, Okamoto M, Taga S, et al. Down-regulation of claudin-2 expression and proliferation by epigenetic inhibitors in human lung adenocarcinoma A549 Cells ［J］. J Biol Chem, 2017, 292(6):2411-2421.

［4］ He P, Li K, Li SB, et al. Upregulation of AKAP12 with HDAC3 depletion suppresses the progression and migration of colorectal cancer ［J］. Int J Oncol, 2018, 52(4):1305-1316.

［5］ Yao J, Qian CJ, Ye B, et al. ERK inhibition enhances TSA-induced gastric cancer cell apoptosis via NF-κB-dependent and Notch-independent mechanism ［J］. Life Sci, 2012, 91(56):186-193.

［6］ Noh H, Park J, Shim M, et al. Trichostatin A enhances estrogen receptor-alpha repression in MCF-7 breast cancer cells under hypoxia ［J］. Biochem Biophys Res Commun, 2016, 470(3):748-752.

［7］ Kahr Ⅰ, Vandepoele K, van Roy F. Delta-protocadherins in health and disease ［J］. Prog Mol Biol Transl Sci, 2013, 116(2013):169-192.

［8］ Chen Y, Xiang H, Zhang Y, et al. Loss of PCDH9 is associated with the differentiation of tumor cells and metastasis and predicts poor survival in gastric cancer ［J］. Clin Exp Metastasis, 2015, 32(5):417-428.

［9］ Wang C, Tao B, Li S, et al. Characterizing the role of PCDH9 in the regulation of glioma cell apoptosis and invasion ［J］. J Mol Neurosci, 2014, 52(2):250-260.

［10］Zhu P, Lv J, Yang Z, et al. Protocadherin 9 inhibits epithelial-mesenchymal transition and cell migration through activating GSK-3β in hepatocellular carcinoma ［J］. Biochem Biophys Res Commun, 2014, 452(3):567-574.

［11］Lü J, Zhu P, Zhang X, et al. PCDH9 acts as a tumor suppressor inducing tumor cell arrest at G0/G1 phase and is frequently methylated in hepatocellular carcinoma ［J］. Mol Med Rep, 2017, 16(4):4475-4482.

［12］Suraweera A, O’Byrne KJ, Richard DJ. Combination therapy with histone deacetylase inhibitors (HDACi) for the treatment of cancer: achieving the full therapeutic potential of HDACi ［J］. Front Oncol, 2018, 8:92.

［13］Codd R, Braich N, Liu J, et al. Zn(Ⅱ)-dependent histone deacetylase inhibitors: suberoylanilide hydroxamic acid and trichostatin A ［J］. Int J Biochem Cell Biol, 2009, 41(4):736-739.

［14］Zhang J, Liu Y, Zhang J, et al. FOXQ1 promotes gastric cancer metastasis through upregulation of Snail ［J］. Oncol Rep, 2016, 35(6):3607-3613.

［15］Zheng JX, Zhu Q, Liu Ch, et al. Expression of interleukin -34/colony stimulating factor -1R in the process of transforming growth factor -β1 inducing A549 cells transition ［J］. Acta Anatomica Sinica, 2014, 45(3): 393-397. (in Chinese)

郑金旭, 朱勤, 刘超, 等. 白细胞介素-34/集落刺激因子-1R在转化生长因子-β1诱导A549细胞上皮-间质转化中的表达［J］. 解剖学报, 2014, 45(3): 393-397.

［16］Okubo K, Uenosono Y, Arigami T, et al. Clinical significance of altering epithelial-mesenchymal transition in metastatic lymph nodes of gastric cancer ［J］. Gastric Cancer, 2017, 20(5):802-810.

［17］Zhu YW, Yan JK, Li JJ, et al. Knockdown of radixin suppresses gastric cancer metastasis in vitro by up-regulation of E-cadherin via NF-κB/Snail pathway ［J］. Cell Physiol Biochem, 2016, 39(6):2509-2521.

［18］Pirooz HJ, Jafari N, Rastegari M, et al. Functional SNP in microRNA-491-5p binding site of MMP9 3'-UTR affects cancer susceptibility ［J］. J Cell Biochem, 2018, 119(7):5126-5134.

［19］Huang Q, Lan F, Wang X, et al. IL-1β-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9 ［J］. Mol Cancer, 2014, 13:18.